The Lancet Regional Health Americas in conversation with
The Lancet Regional Health - America's journal editors, in conversation with their authors, explore their latest open access research and its impact on people’s health, healthcare, and health policy.
The Lancet Regional Health Americas in conversation with
Beatriz Grinsztejn on Lenacapavir and the future of HIV prevention
In this episode, our editor-in-chief Taissa Vila sits down with Dr. Beatriz Grinsztejn to discuss the challenges of expanding access to pre-exposure prophylaxis (PrEP), with a focus on issues of adherence and equity in Latin America.
We explore the potential of Lenacapavir as a game-changing intervention, reflect on lessons learned from previous experiences with injectable PrEP, and examine the critical importance of introducing new prevention tools through an equity-based approach.
Finally, we look ahead to what Lenacapavir could mean for the future of HIV prevention strategies worldwide. Tune in for an insightful conversation on how innovative strategies like Lenacapavir could reshape the future of HIV awareness and prevention.
Read the full article: